Costs of illness due to Bordetella pertussis in families

被引:53
作者
Lee, LH
Pichichero, ME
机构
[1] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA
[2] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA
关键词
D O I
10.1001/archfami.9.10.989
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess costs of pertussis morbidity among families in a community setting. Design: Prospective survey. Results: Sixty-nine families (87 individuals) were studied. Twelve of 14 families with household contacts included an ill adolescent or parent. This individual was the first identified pertussis case within the household in 8 families. A family member required an average of 1.6 visits before (range, 0-7 visits) and after (range, 0-9 visits) pertussis was diagnosed; children younger than 1 year needed 2.5 and 2 visits, respectively. Symptomatic improvement occurred after a mean of 31 days (range, 4-134 days) after pertussis diagnosis and full recovery after a mean of 66 days (range, 5-383 days). Adults experienced the longest recovery time (median, 93 days) compared with other age groups. The average medical costs for an infant, child, adolescent, and adult were $2822, $308, $254, and $181, respectively. Parents lost an average of 6 workdays (range, 1-35 days) to care for an ill child; for these parents, costs associated with work loss averaged $767 per family. An average of 1.7 and 0.7 lost workdays accrued to bring an ill child to a physician's office and the emergency department, respectively. A majority (58%) of parents working while family members were ill with pertussis reported decreased work productivity ranging from 25% to 99%. Work-related costs contributed more than 60% of the overall costs of pertussis. Conclusions: The adverse financial effect of pertussis on 69 families in Monroe County, New York, was $145903 ($2115 per family) and supports the need for booster immunizations in adolescents and adults.
引用
收藏
页码:989 / 996
页数:8
相关论文
共 34 条
[1]  
[Anonymous], 1997, MMWR Recomm Rep, V46, P1
[2]   Parental benefit policies and the gendered division of labor [J].
Baker, M .
SOCIAL SERVICE REVIEW, 1997, 71 (01) :51-71
[3]  
*CDCP, 1998, MMWR-MORBID MORTAL W, V47, P67
[4]  
*CDCP, 1993, MMWR-MORBID MORTAL W, V42, P952
[5]   UNRECOGNIZED PERTUSSIS INFECTION IN ADOLESCENTS [J].
CROMER, BA ;
GOYDOS, J ;
HACKELL, J ;
MEZZATESTA, J ;
DEKKER, C ;
MORTIMER, EA .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1993, 147 (05) :575-577
[6]  
EDWARDS KM, 1999, JAMA-J AM MED ASSOC, V269, P53
[7]   Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997 [J].
Ekwueme, DU ;
Strebel, PM ;
Hadler, SC ;
Meltzer, MI ;
Allen, JW ;
Livengood, JR .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2000, 154 (08) :797-803
[8]  
FINE PEM, 1982, LANCET, V1, P166
[9]   USE OF A CHINESE-HAMSTER OVARY CELL CYTO-TOXICITY ASSAY FOR THE RAPID DIAGNOSIS OF PERTUSSIS [J].
HALPERIN, SA ;
BORTOLUSSI, R ;
KASINA, A ;
WORT, AJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (01) :32-38
[10]   Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine hot not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection [J].
Heininger, U ;
Stehr, K ;
Christenson, P ;
Cherry, JD .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (03) :602-604